Delivery Order SPE2DB20D3111-SPE2DB24FA8LL
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$8.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,601.78 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,896.96 firm fixed-price contract is for the delivery of 4,567,944,220 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of April 17, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,927,167 units of the GARDASIL 9 vaccine syringe (0.5 mL), with a ceiling value of $17,718.03 and a period of performance through April 16, 2025. The contract is not set aside and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $4,066.74, is for the supply of 4,566,035,600 units of the GARDASIL 9 vaccine syringe (0.5 mL) to support federal healthcare programs. The contract has an ultimate completion date of October 8, 2024, and is a firm-fixed-price, non-set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,242.38, is for the delivery of 4,568,116,064 units of the GARDASIL 9 vaccine syringe (0.5 mL). The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $7,842.50 for the supply of 4,564,839,951 units of the GARDASIL 9 SYRINGE 0.5ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 10, 2024. The contract is a firm fixed-price arrangement and does not utilize any set-aside designations. Amerisourcebergen, a major pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML. This $11,765.66 delivery order contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this contract, which is not set aside for any specific business type. This delivery order is part of a larger indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,274.75 firm-fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...